Ameriprise’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Ameriprise's LLY Position: Q3 2026 in Review
Ameriprise increased its Eli Lilly (LLY) stake by 2.6% in Q3 2026, buying an estimated $90.4M and bringing the position to 3,073,253 shares worth $3.56B. The position accounts for 0.72% of the portfolio, ranked #17.
Ameriprise first reported a position in LLY in Q2 2013 and has held it in 54 quarters since. The position peaked at $3.6B in Q2 2026. 4,510 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Ameriprise held 3,073,253 shares of Eli Lilly worth $3.56B as of Q3 2026.
- Ameriprise bought 76,584 Eli Lilly shares in Q3 2026, an estimated $90.4M.
- Eli Lilly made up 0.72% of Ameriprise's portfolio in Q3 2026, its #17 holding.
- Ameriprise first reported a position in Eli Lilly in Q2 2013 and has held it in 54 quarters since.
- Ameriprise's Eli Lilly position peaked at $3.6B in Q2 2026.
- 4,510 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.